Four coronavirus patients with acute respiratory distress syndrome, a life-threatening condition that affects the lungs, have been enrolled in a study at the Intermountain Medical Center in Murray and the University of Utah Hospital in Salt Lake City as part of a new National Institute of Health-sponsored trial of treatments for the “sickest of the sick” COVID-19 patients.
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaboration
A centrally led implementation strategy with local site tailoring led to faster delivery of tPA across disparate EDs in a multihospital system with no change…
Vitamin E Acetate is Associated with Select Proinflammatory Cytokines: An Analysis of a 2020-2022 Cohort of EVALI Patients
Rationale: It is unclear whether extracorporeal CO2 removal (ECCO2R) can reduce the rate of intubation or the total time on invasive mechanical ventilation (IMV) in…
“NYC Health + Hospitals joins NYC and its department of education in a lawsuit against social media giants, alleging they have caused a youth mental…
Program: Oral and Poster Abstracts Session: 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II Hematology Disease Topics & Pathways: Lymphoid Leukemias, ALL,…
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia,…
This platform randomized clinical trial examines the effectiveness of ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of…
Official websites use .gov A.gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or…
